Gel4Med, Inc.

Read our most recent press release on our feature in Podiatry Today as a Top 10 Innovation in Wound Care and learn how Gel4Med is shaping the future of wound care with their novel biomaterials approach.    #PodiatryToday #MedicalDevice #Innovation #HarvardInnovationLabs #UmassM2D2 #WoundCare #TissueRegeneration #SurgicalWoundClosure #TherapeuticMaterials #Biomaterials #Surgery #HealthcareInnovation #MedTech #Biotech #TissueEngineering #RegenerativeMedicine #PatientCare #Gel4Med

🎉 Exciting News!🎉 Gel4Med is thrilled to announce that Podiatry Today has recognized Gel4Med’s innovative product, G4Derm Plus, as one of the Top 10 Innovations in Podiatry. This achievement reflects the relentless dedication of the Gel4Med team to design and develop transformative technology focused on advancing biomaterials and patient outcomes. Our deepest gratitude extends to Dr. Stephanie Wu, DPM for her support in recognition of our technology as an innovative solution in wound care, along with our clinical collaborators. Their steadfast belief and support in our team and technology continue to guide us through challenges and push the boundaries of innovation. We’re just getting started, and we invite you to be part of this exciting journey. Gel4Med invites those attending the Symposium on Advanced Wound Care (SAWC) Fall Conference in Las Vegas, October 2-5, 2024, to connect with the team to learn more about the Company’s portfolio and engineered biomaterials solutions.  Gel4Med isn’t just building products; we’re cultivating a community of innovators and change-makers. Whether you’re interested in partnerships, strategic/distribution opportunities, or investing, there’s a place for you here. If you’re interested in partnering with the Company, please get in touch with our team at [email protected]  For more information on the recognition, we invite you to read about the Top 10 Innovations in Podiatry Today. Stay tuned for updates on the launch and availability of G4Derm and G4Derm Plus in 2024. #PodiatryToday #MedicalDevice #Innovation #HarvardInnovationLabs #UmassM2D2 #WoundCare #TissueRegeneration #SurgicalWoundClosure #TherapeuticMaterials #Biomaterials #Surgery #HealthcareInnovation #MedTech #Biotech #TissueEngineering #RegenerativeMedicine #PatientCare #Gel4Med

🎙 Exciting News! 🎉 Gel4Med is thrilled to announce that our Associate Director of Product Development, Ana Tellechea, PharmD, PhD will be delivering a podium presentation at the Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) 2024 Conference on May 16th at 10:30am! A few words from Dr. Tellechea, “I am honored to have the opportunity to share Gel4Med’s recent findings in the field of wound care at this esteemed event. My presentation will delve into the antimicrobial protection and superior wound healing outcomes of our innovative biomimetic matrix product, and I look forward to receiving high-quality feedback from researchers, clinicians, and industry representatives alike.”  The SAWC Spring | WHS Conference is renowned for bringing together thought leaders, practitioners, and researchers in wound care from around the globe, providing a platform for collaboration, learning, and advancing the field. We are eager to strengthen our active contribution to this vibrant community and engage in meaningful discussions that drive progress and improve patient outcomes. We look forward to connecting with colleagues, exchanging ideas, and exploring new opportunities for collaboration at the SAWC Spring | WHS 2024 conference. If you're attending the event, we would be delighted to meet you at Dr. Tellechea’s presentation or connect during the conference. Thank you to the organizers of the SAWC and WHS joint annual meeting for this incredible opportunity. We can't wait to see you all in Orlando! #SAWC #WHS #WoundHealing #WoundCare #ConferencePresentation #Networking #Innovation #HealthcareLeadership #Biomaterials #SmartMaterials

Unleashing our cell delivery platform for solving unmet clinical needs in Spinal Cord Injury! Onwards and Upwards 🎉

🎉 Great News from Gel4Med! 🎉 We are thrilled to announce a pivotal three-year research collaboration with Dr. Damien Pearse, Ph.D., Professor of Neurological Surgery at the University of Miami Miller School of Medicine, supported by a Department of Defense (DoD) grant. Rebecca Salamone, MS, our Manager of Business Development for North America, shares her excitement: "We are incredibly excited about the potential of our collaboration with Dr. Pearse and the University of Miami. This partnership allows us to push the boundaries of medical technology, exploring innovative approaches to treat spinal cord injuries that could fundamentally change patient care. We're eager to develop technologies that are not only groundbreaking but also make a direct impact." Our Mission: · Innovative Cell Therapy: Utilizing Gel4Med’s proprietary Smart Materials Platform™, we aim to revolutionize treatment for spinal cord injuries by delivering Schwann cells directly to the lesion sites. · Esteemed Partnership: Collaborating with the University of Miami/Miami Project to Cure Paralysis, renowned for its academic excellence and pioneering research in spinal cord injury. We are incredibly proud to join forces on this venture and are eager to share the impactful breakthroughs that will undoubtedly emerge from our joint efforts. 🌟 Here's to groundbreaking discoveries and innovations ahead! For more details, read the full story here: The Miami Project and Gel4Med, Inc., Collaborate to Study Novel Approach to Spinal Cord Injuries - InventUM. #Innovation #Biomaterials #Gel4Med #SyntheticBiology #ImpactfulResearch #AcademicAchievements #Collaboration #DepartmentOfDefense #Research #SpinalCordInjury

🎉 Great News from Gel4Med! 🎉 We are thrilled to announce a pivotal three-year research collaboration with Dr. Damien Pearse, Ph.D., Professor of Neurological Surgery at the University of Miami Miller School of Medicine, supported by a Department of Defense (DoD) grant. Rebecca Salamone, MS, our Manager of Business Development for North America, shares her excitement: "We are incredibly excited about the potential of our collaboration with Dr. Pearse and the University of Miami. This partnership allows us to push the boundaries of medical technology, exploring innovative approaches to treat spinal cord injuries that could fundamentally change patient care. We're eager to develop technologies that are not only groundbreaking but also make a direct impact." Our Mission: · Innovative Cell Therapy: Utilizing Gel4Med’s proprietary Smart Materials Platform™, we aim to revolutionize treatment for spinal cord injuries by delivering Schwann cells directly to the lesion sites. · Esteemed Partnership: Collaborating with the University of Miami/Miami Project to Cure Paralysis, renowned for its academic excellence and pioneering research in spinal cord injury. We are incredibly proud to join forces on this venture and are eager to share the impactful breakthroughs that will undoubtedly emerge from our joint efforts. 🌟 Here's to groundbreaking discoveries and innovations ahead! For more details, read the full story here: The Miami Project and Gel4Med, Inc., Collaborate to Study Novel Approach to Spinal Cord Injuries - InventUM. #Innovation #Biomaterials #Gel4Med #SyntheticBiology #ImpactfulResearch #AcademicAchievements #Collaboration #DepartmentOfDefense #Research #SpinalCordInjury

🙏 Heartfelt Gratitude and exciting Times Ahead! 🚀 I want to extend my deepest gratitude to every individual who has been part of this incredible journey. Here’s to breaking boundaries, creating impact, and transforming the future of medicine together! 💙

We are thrilled to announce that Gel4Med's innovative products, G4Derm and G4Derm Plus, have received FDA clearance. #MedicalDevice #Innovation #HarvardInnovationLabs #UmassM2D2 #WoundCare #TissueRegeneration #SurgicalWoundClosure #TherapeuticMaterials #Biomaterials #Surgery #HealthcareInnovation #MedTech #Biotech #TissueEngineering #RegenerativeMedicine #PatientCare #Gel4Med #BreakoutVentures #MassVentures

🎉 Exciting News from Gel4Med! 🎉 We are thrilled to announce that our team at Gel4Med has been awarded significant funding from the highly competitive National Institutes of Health Commercial Readiness Pilot (CRP) program! 🏆 This significant milestone propels the commercial launch of our lead asset, G4M-01, in 2024!🚀 🗣️ A Word from Our CEO, Manav Mehta: "This endorsement from NIH not only accelerates our innovative journey but also affirms our dedication to impacting patient care globally. G4M-01 emerges as a pivotal innovation, ensuring effective wound care and safeguarding surgical outcomes in the operating room for patients across the globe." 🔍 Spotlight on G4M-01: Utilizing synthetic biology and advanced materials design, G4M-01 delivers infection-free wound closure, marking its place as the first-in-class bio-synthetic material in its category. By eliminating dependence on traditional antibiotics and animal-based biomaterials, G4M-01 epitomizes our commitment to pioneering, secure, and potent therapeutic solutions. 🤝 A Collective Effort: Our journey is backed by numerous esteemed entities, including Peter Thiel/Breakout Labs, NIH, DoD, NSF, MLSC, and Mass Ventures, supporting our vision and consistent efforts to address diverse unmet clinical needs. 🙏 Thank You: A huge thanks to our incredible team and advisors at Gel4Med and all our supporters as we continue navigating the path towards innovative devices and therapeutics that address unmet clinical needs in applications like tissue regeneration, cell delivery, and drug delivery. 🤝 Join Us in Our Journey: Whether through partnerships, career opportunities, or investments, there's a place for you with Gel4Med. Stay connected and follow us as we continue our mission to transform the therapeutic materials landscape. #Gel4Med #Funding #Innovation #WoundCare #TissueRegeneration #SurgicalWoundClosure #TherapeuticMaterials #Biomaterials #Surgery #HealthcareInnovation #MedTech #Biotech #TissueEngineering #Investment #MassVentures #BreakoutVentures